Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis

Cancer Cell

Volumn 5, Issue 5, 2004, Pages 443-453

  Joyce, Johanna A ^a,b   Baruch, Amos ^a,d   Chehade, Kareem ^a,d   Meyer Morse, Nicole ^a,b   Giraudo, Enrico ^a,b   Tsai, Fong Ying ^c   Greenbaum, Doron C ^a   Hager, Jeffrey H ^a,b   Bogyo, Matthew ^a,e   Hanahan, Douglas ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MILLENNIUM PHARMACEUTICALS INC   (United States)

^d CELERA   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; CYSTEINE CATHEPSIN INHIBITOR; ENZYME INHIBITOR; JPM 565; PROTEINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER INVASION; CANCER MODEL; CARCINOGENESIS; CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE EXPRESSION PROFILING; IMAGE ANALYSIS; IMMUNOCOMPETENT CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PANCREAS ISLET CELL TUMOR; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; TUMOR GROWTH; TUMOR VASCULARIZATION; UPREGULATION; UTERINE CERVIX CANCER; WART VIRUS;

ANIMALIA; HUMAN PAPILLOMAVIRUS TYPES;

EID: 2342603891     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(04)00111-4     Document Type: Article

References (58)

1. Arbeit J.M., Howley P.M., Hanahan D. Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. Proc. Natl. Acad. Sci. USA. 93:1996;2930-2935
2. Balaji K.N., Schaschke N., Machleidt W., Catalfamo M., Henkart P.A. Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation. J. Exp. Med. 196:2002;493-503
3. Bergers G., Javaherian K., Lo K.M., Folkman J., Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science. 284:1999;808-812
4. Bergers G., Brekken R., McMahon G., Vu T.H., Itoh T., Tamaki K., Tanzawa K., Thorpe P., Itohara S., Werb Z., Hanahan D. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2:2000;737-744
5. Bergers G., Song S., Meyer-Morse N., Bergsland E., Hanahan D. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J. Clin. Invest. 111:2003;1287-1295
6. Bogyo M., Verhelst S., Bellingard-Dubouchaud V., Toba S., Greenbaum D. Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs. Chem. Biol. 7:1999;27-38
7. Bremer C., Tung C.H., Weissleder R. In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat. Med. 7:2001;743-748
8. Brix K., Linke M., Tepel C., Herzog V. Cysteine proteinases mediate extracellular prohormone processing in the thyroid. Biol. Chem. 382:2001;717-725
9. Buck M.R., Karustis D.G., Day N.A., Honn K.V., Sloane B.F. Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. Biochem. J. 282:1992;273-278
10. Carmeliet P. Angiogenesis in health and disease. Nat. Med. 9:2003;653-660
11. Christofori G., Naik P., Hanahan D. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature. 369:1994;414-418
12. Coussens L.M., Werb Z. Inflammation and cancer. Nature. 420:2002;860-867
13. Coussens L.M., Hanahan D., Arbeit J.M. Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice. Am. J. Pathol. 149:1996;1899-1917
14. Elson D.A., Riley R.R., Lacey A., Thordarson G., Talamantes F.J., Arbeit J.M. Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis. Cancer Res. 60:2000;1267-1275
15. Elson D.A., Thurston G., Huang L.E., Ginzinger D.G., McDonald D.M., Johnson R.S., Arbeit J.M. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. Genes Dev. 15:2001;2520-2532
16. Engel J.C., Doyle P.S., Hsieh I., McKerrow J.H. Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection. J. Exp. Med. 188:1998;725-734
17. Foghsgaard L., Wissing D., Mauch D., Lademann U., Bastholm L., Boes M., Elling F., Leist M., Jaattela M. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 153:2001;999-1010
18. Folkman J., Watson K., Ingber D., Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature. 339:1989;58-61
19. Greenbaum D., Medzihradszky K.F., Burlingame A., Bogyo M. Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools. Chem. Biol. 7:2000;569-581
20. Greenbaum D., Baruch A., Hayrapetian L., Darula Z., Burlingame A., Medzihradszky K.F., Bogyo M. Chemical approaches for functionally probing the proteome. Mol. Cell. Proteomics. 1:2002;60-68
21. Hanahan D. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature. 315:1985;115-122
22. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70
23. Holash J., Maisonpierre P.C., Compton D., Boland P., Alexander C.R., Zagzag D., Yancopoulos G.D., Wiegand S.J. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science. 284:1999;1994-1998
24. Huh C.G., Hakansson K., Nathanson C.M., Thorgeirsson U.P., Jonsson N., Grubb A., Abrahamson M., Karlsson S. Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene. Mol. Pathol. 52:1999;332-340
25. Inoue M., Hager J.H., Ferrara N., Gerber H.P., Hanahan D. VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis. Cancer Cell. 1:2002;193-202
26. Ito K., Okamoto I., Araki N., Kawano Y., Nakao M., Fujiyama S., Tomita K., Mimori T., Saya H. Calcium influx triggers the sequential proteolysis of extracellular and cytoplasmic domains of E-cadherin, leading to loss of beta-catenin from cell-cell contacts. Oncogene. 18:1999;7080-7090
27. Kalluri R. Basement membranes. structure, assembly and role in tumour angiogenesis Nat. Rev. Cancer. 3:2003;422-433
28. Kinzler K.W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 87:1996;159-170
29. Koblinski J.E., Ahram M., Sloane B.F. Unraveling the role of proteases in cancer. Clin. Chim. Acta. 291:2000;113-135
30. Koblinski J.E., Dosescu J., Sameni M., Moin K., Clark K., Sloane B.F. Interaction of human breast fibroblasts with collagen I increases secretion of procathepsin B. J. Biol. Chem. 277:2002;32220-32227
31. Konduri S.D., Yanamandra N., Siddique K., Joseph A., Dinh D.H., Olivero W.C., Gujrati M., Kouraklis G., Swaroop A., Kyritsis A.P., Rao J.S. Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene. 21:2002;8705-8712
32. Lah T.T., Kos J. Cysteine proteinases in cancer progression and their clinical relevance for prognosis. Biol. Chem. 379:1998;125-130
33. Lopez T., Hanahan D. Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis. Cancer Cell. 1:2002;339-353
34. McKerrow J.H., Engel J.C., Caffrey C.R. Cysteine protease inhibitors as chemotherapy for parasitic infections. Bioorg. Med. Chem. 7:1999;639-644
35. Meara J.P., Rich D.H. Mechanistic studies on the inactivation of papain by epoxysuccinyl inhibitors. J. Med. Chem. 39:1996;3357-3366
36. Morita M., Yoshiuchi N., Arakawa H., Nishimura S. Cmap. a novel cystatin-like gene involved in liver metastasis Cancer Res. 59:1999;151-158
37. Mort J.S., Recklies A.D., Poole A.R. Release of cathepsin B precursors from human and murine tumours. Prog. Clin. Biol. Res. 180:1985;243-245
38. Naik P., Karrim J., Hanahan D. The rise and fall of apoptosis during multistage tumorigenesis. down-modulation contributes to tumor progression from angiogenic progenitors Genes Dev. 10:1996;2105-2116
39. Parangi S., Dietrich W., Christofori G., Lander E.S., Hanahan D. Tumor suppressor loci on mouse chromosomes 9 and 16 are lost at distinct stages of tumorigenesis in a transgenic model of islet cell carcinoma. Cancer Res. 55:1995;6071-6076
40. Perl A.K., Wilgenbus P., Dahl U., Semb H., Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature. 392:1998;190-193
41. Rao J.S. Molecular mechanisms of glioma invasiveness. the role of proteases Nat. Rev. Cancer. 3:2003;489-501
42. Recklies A.D., White C., Mitchell J., Poole A.R. Secretion of a cysteine proteinase from a hormone-independent cell population of cultured explants of murine mammary gland. Cancer Res. 45:1985;2294-2301
43. Rios-Doria J., Day K.C., Kuefer R., Rashid M.G., Chinnaiyan A.M., Rubin M.A., Day M.L. The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells. J. Biol. Chem. 278:2003;1372-1379
44. Roshy S., Sloane B.F., Moin K. Pericellular cathepsin B and malignant progression. Cancer Metastasis Rev. 22:2003;271-286
45. Shi G.P., Munger J.S., Meara J.P., Rich D.H., Chapman H.A. Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. J. Biol. Chem. 267:1992;7258-7262
46. Shi G.P., Sukhova G.K., Kuzuya M., Ye Q., Du J., Zhang Y., Pan J.H., Lu M.L., Cheng X.W., Iguchi A., et al. Deficiency of the cysteine protease cathepsin S impairs microvessel growth. Circ. Res. 92:2003;493-500
47. Shridhar R., Zhang J., Song J., Booth B.A., Kevil C.G., Sotiropoulou G., Sloane B.F., Keppler D. Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells. Oncogene. in press:2003
48. Smith-McCune K., Zhu Y.H., Hanahan D., Arbeit J. Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice. Cancer Res. 57:1997;1294-1300
49. Strathdee G. Epigenetic versus genetic alterations in the inactivation of E-cadherin. Semin. Cancer Biol. 12:2002;373-379
50. Tamayo P., Slonim D., Mesirov J., Zhu Q., Kitareewan S., Dmitrovsky E., Lander E.S., Golub T.R. Interpreting patterns of gene expression with self-organizing maps. methods and application to hematopoietic differentiation Proc. Natl. Acad. Sci. USA. 96:1999;2907-2912
51. Tung C.H., Mahmood U., Bredow S., Weissleder R. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res. 60:2000;4953-4958
52. Turk V., Turk B., Turk D. Lysosomal cysteine proteases. facts and opportunities EMBO J. 20:2001;4629-4633
53. Turk V., Turk B., Guncar G., Turk D., Kos J. Lysosomal cathepsins. structure, role in antigen processing and presentation, and cancer Adv. Enzyme Regul. 42:2002;285-303
54. Utsunomiya T., Hara Y., Kataoka A., Morita M., Arakawa H., Mori M., Nishimura S. Cystatin-like metastasis-associated protein mRNA expression in human colorectal cancer is associated with both liver metastasis and patient survival. Clin. Cancer Res. 8:2002;2591-2594
55. Vleminckx K., Vakaet L. Jr., Mareel M., Fiers W., van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell. 66:1991;107-119
56. Wu X., Pandolfi P.P. Mouse models for multistep tumorigenesis. Trends Cell Biol. 11:2001;S2-S9
57. Yan S., Sameni M., Sloane B.F. Cathepsin B and human tumor progression. Biol. Chem. 379:1998;113-123
58. Yasothornsrikul S., Greenbaum D., Medzihradszky K.F., Toneff T., Bundey R., Miller R., Schilling B., Petermann I., Dehnert J., Logvinova A., et al. Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter. Proc. Natl. Acad. Sci. USA. 100:2003;9590-9595